Beta-Nicotinamide Adenine Dinucleotide Sodium Salt

Basic Information

View in Editor

CAS Number

20111-18-6

Molecular Formula

C21H26N7NaO14P2

Molecular Weight

685.4 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Amines

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Agricultural Chemicals Pesticides Insecticides

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

SMILES

View in Editor

C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)([O-])OP(=O)([O-])OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N.[Na+]

InChI

InChI=1S/C21H27N7O14P2.Na/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33;/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37);/q;+1/p-1/t10-,11-,13-,14-,15-,16-,20-,21-;/m1./s1

InChIKey

OGCURMAMSJFXSG-QYZPTAICSA-M

LogP

-0.85800

Complexity

1110

Safety Information

View Safety Information

Hazard Statement

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Sensitiveness

Hygroscopic

Synonyms & References

English

sodium;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate
beta-Dpn sodium salt
Nad sodium salt
beta-Nicotinamide Adenine Dinucleotide Sodium Salt
-DPN (sodium salt);-NAD (sodium salt);-Nicotinamide Adenine Dinucleotide (sodium salt)
Q27274259
ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE), P'->5'-ESTER WITH 3-(AMINOCARBONYL)-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM, INNER SALT, SODIUM SALT (1:1)
B1N53L892B
Nicotinamide-adenine dinucleotide monosodium salt
Adenosine 5'-(trihydrogen diphosphate), p'->5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt, sodium salt (1:1)
Adenosine5'-(trihydrogen diphosphate),p'(R)5'-ester with 3-(aminocarbonyl)-1-b-D-ribofuranosylpyridinium,inner salt,monosodiumsalt(9ci)
UNII-B1N53L892B
20111-18-6
Nadide sodium
Adenosine5'-(trihydrogen diphosphate), P'&reg
5'-ester with 3-(aminocarbonyl)-1-b-D-ribofuranosylpyridinium, inner salt, monosodiumsalt (9CI)
β-Nicotinamide adenine dinucleotide sodium salt
B-NICOTINAMIDE ADENINE DINUCLEOTIDE SODIUM SALT DIHYDRATE
B-nicotinamide adenine dinucleotide*sodium approx
COENZYME 1 SODIUM SALT
COZYMASE SODIUM SALT
DIPHOSPHOPYRIDINE NUCLEOTIDE SODIUM SALT
DPN SODIUM SALT
NAD sodium
NAD SODIUM SALT
NADIDE SODIUM SALT
Nicotinamide adenine dinucleotide sodium salt
DPN
NAD
Nadide
β-DPN

MDL Number

MFCD00148917

FAQ

What regulatory guidelines apply to Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6)?

Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6) is subject to various regulatory guidelines. It falls under the classification of food additives and pharmaceuticals. In the US, it is regulated by the FDA for use in food and pharmaceuticals, while the EPA oversees its environmental impact. In the EU, it is regulated under REACH, which includes risk assessment and registration requirements for chemicals.

Are there alternatives to Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6) in synthesis?

Alternatives to Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6) in synthesis include using the free base form or other nucleotide analogs. Isomers or structural analogs like deoxyadenosine monophosphate sodium salt can also be used as substitutes, depending on the specific application in biochemistry or pharmacology.

What is the market or research trend for Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6)?

The market trend for Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6) is showing steady growth, particularly in the pharmaceutical and biotech sectors. Research is focusing on its role in cellular metabolism, aging, and potential therapeutic applications. Recent studies are exploring its use in developing treatments for neurological disorders and cancer.

How should waste containing Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6) be handled?

Waste containing Beta-Nicotinamide Adenine Dinucleotide Sodium Salt (CAS: 20111-18-6) should be handled with care to ensure environmental safety. Collect waste in appropriate containers, and follow local disposal regulations. It is recommended to incinerate or dispose of the waste through a professional hazardous waste management service. Always ensure proper personal protective equipment is used and follow local environmental protection guidelines.